SYNDAX PHARMACEUTICALS INC (SNDX) Stock Income Statement
NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 43.72M | 23.68M | 0.00 | 0.00 | 139.70M | |||
| Cost Of Goods | N/A | 826.00K | N/A | N/A | N/A | |||
| Gross Profit | N/A | 22.85M | N/A | N/A | N/A | |||
| Operating Expenses | 385.68M | 362.53M | 229.95M | 151.80M | 113.50M | |||
| Research and Development | 246.79M | 241.65M | 163.03M | 118.50M | 88.20M | |||
| Selling, General, and Administrative Expenses | 138.89M | 120.88M | 66.92M | 33.30M | 25.20M | |||
| Operating Income | -343.67M | -339.67M | -229.95M | -151.80M | 26.20M | |||
| Interest Income/Expense | 13.09M | 21.16M | 20.95M | 2.70M | -1.50M | |||
| Other Income/Expense | -381.00K | -247.00K | -361.00K | -300.00K | 200.00K | |||
| Income Before Taxes | -331.20M | -318.76M | -209.36M | -149.30M | 24.90M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -331.20M | -318.76M | -209.36M | -149.30M | 24.90M | |||
| EBITDA | N/A | -339.66M | -229.94M | -151.77M | 26.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.86 | -3.72 | -2.98 | -2.46 | 0.46 | |||
| Non GAAP EPS | -3.86 | -3.73 | -2.96 | -2.45 | 0.43 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 96.51% | N/A | N/A | N/A | |||
| Profit Margin | -757.52% | -1346.11% | N/A | N/A | 17.82% | |||
| Operating Profit Margin | -786.03% | -1434.43% | N/A | N/A | 18.75% | |||
All data in USD